These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 9002124
1. Use of fluoroquinolones as prophylactic agents in patients with neutropenia. Patrick CC. Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124 [Abstract] [Full Text] [Related]
2. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future. Young LS. Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):93-7. PubMed ID: 3132393 [Abstract] [Full Text] [Related]
3. Use of selective decontamination in the prevention of infection after accidental irradiation. A review. Brook I, Ledney GD. Prehosp Disaster Med; 1993 Feb; 8(1):85-8. PubMed ID: 10155457 [Abstract] [Full Text] [Related]
4. The use of fluoroquinolones in neutropenic patients--analysis of adverse effects. Rubinstein E, Potgieter P, Davey P, Norrby SR. J Antimicrob Chemother; 1994 Jul; 34(1):7-19. PubMed ID: 7961217 [Abstract] [Full Text] [Related]
5. Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts. Maschmeyer G. Drugs; 1993 Jul; 45 Suppl 3():73-80. PubMed ID: 7689455 [Abstract] [Full Text] [Related]
6. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance. Garnica M, Nouér SA, Pellegrino FL, Moreira BM, Maiolino A, Nucci M. BMC Infect Dis; 2013 Jul 31; 13():356. PubMed ID: 23899356 [Abstract] [Full Text] [Related]
7. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity. Martino R, Subira M, Altés A, López R, Sureda A, Domingo-Albós A, Pericas R, Brunet S. Acta Haematol; 1998 Jul 31; 99(4):206-11. PubMed ID: 9644298 [Abstract] [Full Text] [Related]
8. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. Qin TJ, Mi YC, Feng SZ, Li DP, Wei JL, Yang DL, Han MZ, Wang JX, Bian SG. Zhonghua Yi Xue Za Zhi; 2007 May 29; 87(20):1389-93. PubMed ID: 17785058 [Abstract] [Full Text] [Related]
9. The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients. Del Favero A, Menichetti F. Eur J Cancer; 1993 May 29; 29A Suppl 1():S2-6. PubMed ID: 8427721 [Abstract] [Full Text] [Related]
10. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series. Wojenski DJ, Barreto JN, Wolf RC, Tosh PK. Clin Ther; 2014 Jun 01; 36(6):976-81. PubMed ID: 24832560 [Abstract] [Full Text] [Related]
11. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial. Lee DG, Choi SM, Choi JH, Yoo JH, Park YH, Kim YJ, Lee S, Min CK, Kim HJ, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Korean J Intern Med; 2002 Mar 01; 17(1):38-44. PubMed ID: 12014211 [Abstract] [Full Text] [Related]
12. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Ann Intern Med; 2005 Jun 21; 142(12 Pt 1):979-95. PubMed ID: 15968013 [Abstract] [Full Text] [Related]
13. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients. Bow EJ. Curr Opin Infect Dis; 2011 Dec 21; 24(6):545-53. PubMed ID: 22001945 [Abstract] [Full Text] [Related]
14. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance. Prentice HG, Hann IM, Nazareth B, Paterson P, Bhamra A, Kibbler CC. Br J Haematol; 2001 Oct 21; 115(1):46-52. PubMed ID: 11722408 [Abstract] [Full Text] [Related]
15. [Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?]. Dubos F, Delebarre M, Lagrée M. Arch Pediatr; 2013 Nov 21; 20 Suppl 3():S90-3. PubMed ID: 24360309 [Abstract] [Full Text] [Related]